Cargando…
Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers
The co-existence of breast and ovarian cancers in the same individual should raise suspicion of a hereditary process. Patients with either BRCA1 or BRCA2 germ-line mutations have an average risk of 39% and 11% respectively of developing ovarian cancer by the age of 70; they have a risk of 35–85% of...
Autores principales: | Dilawari, A, Cangiarella, J, Smith, J, Huang, A, Downey, A, Muggia, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234065/ https://www.ncbi.nlm.nih.gov/pubmed/22275985 http://dx.doi.org/10.3332/ecancer.2008.109 |
Ejemplares similares
-
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice
versa
por: Staff, S, et al.
Publicado: (2001) -
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers
por: Vos, Shoko, et al.
Publicado: (2015) -
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016) -
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010) -
A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer
por: Smith, J, et al.
Publicado: (2009)